WallStSmart

Amrize Ltd (AMRZ)vsMP Materials Corp (MP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Amrize Ltd generates 3327% more annual revenue ($11.91B vs $347.57M). AMRZ leads profitability with a 9.7% profit margin vs -20.5%. AMRZ earns a higher WallStSmart Score of 49/100 (D+).

AMRZ

Hold

49

out of 100

Grade: D+

Growth: 4.0Profit: 5.0Value: 5.7Quality: 5.0
Piotroski: 2/9Altman Z: 1.61

MP

Avoid

28

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 4.0Quality: 7.5
Piotroski: 4/9Altman Z: 1.53
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AMRZ.

MPSignificantly Overvalued (-55.4%)

Margin of Safety

-55.4%

Fair Value

$37.03

Current Price

$65.45

$28.42 premium

UndervaluedFair: $37.03Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ1 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

MP1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
118.6%10/10

Revenue surging 118.6% year-over-year

Areas to Watch

AMRZ4 concerns · Avg: 4.0/10
P/E RatioValuation
25.2x4/10

Moderate valuation

Revenue GrowthGrowth
4.7%4/10

4.7% revenue growth

EPS GrowthGrowth
3.6%4/10

3.6% earnings growth

Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

MP4 concerns · Avg: 2.5/10
Altman Z-ScoreHealth
1.534/10

Distress zone — elevated risk

Return on EquityProfitability
-3.0%2/10

ROE of -3.0% — below average capital efficiency

EPS GrowthGrowth
-55.6%2/10

Earnings declined 55.6%

Free Cash FlowQuality
$-79.28M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book. PEG of 1.42 suggests the stock is reasonably priced for its growth.

Bull Case : MP

The strongest argument for MP centers on Revenue Growth. Revenue growth of 118.6% demonstrates continued momentum.

Bear Case : AMRZ

The primary concerns for AMRZ are P/E Ratio, Revenue Growth, EPS Growth.

Bear Case : MP

The primary concerns for MP are Altman Z-Score, Return on Equity, EPS Growth.

Key Dynamics to Monitor

AMRZ profiles as a value stock while MP is a hypergrowth play — different risk/reward profiles.

MP is growing revenue faster at 118.6% — sustainability is the question.

MP generates stronger free cash flow (-79M), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AMRZ scores higher overall (49/100 vs 28/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology company at the forefront of the digital health and wellness sector, dedicated to transforming healthcare delivery through advanced technologies and data-driven solutions. With a strong focus on improving patient outcomes and enhancing accessibility, Amrize invests significantly in research and development to meet the growing demand for scalable health innovations. Its strategic initiatives and diverse product offerings position the company as a key player in modern healthcare transformation, presenting a compelling opportunity for institutional investors in a rapidly evolving market.

Visit Website →

MP Materials Corp

BASIC MATERIALS · OTHER INDUSTRIAL METALS & MINING · USA

MP Materials Corp. The company is headquartered in Las Vegas, Nevada.

Want to dig deeper into these stocks?